BioHealth News Archive
Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine
- NVX-CoV2373 demonstrated overall efficacy of ~90% in PREVENT-19 clinical trial conducted during the emergence of variant strains GAITHERSBURG, Md., Jan. 31, 2022 /PRNewswire/…
Read More
BioHealth Innovation Announces Updates to its Board of Directors
Board of Directors Elects New Chair, Vice-Chair, and Two New Members ROCKVILLE, MARYLAND, January 31, 2021 – The Board of Directors of BioHealth Innovation,…
Read More
Opportunity: Entrepreneur-In-Residence Role with BioHealth Innovation, Inc. and NIH
POSITION DESCRIPTION – Entrepreneur-In-Residence EIRs will work in collaboration with SEED to mentor innovators and provide guidance to help them de-risk the technical and…
Read More
5 Cities Emerging As Future Hubs For Life Sciences Development
The current boom in life sciences development mirrors the tech industry, especially geographically; there is an incredible concentration of jobs and investment in the top…
Read More
Pandemic Preparedness: The next best time to act is now – Emergent BioSolutions
Global public health is at a critical inflection point. Do we learn the lessons of this pandemic and build a modern public health infrastructure…
Read More
Novavax and Israel Announce Advance Purchase Agreement for Supply of COVID-19 Vaccine
The Novavax vaccine would be the first protein-based alternative available in Israel GAITHERSBURG, Md., Jan. 28, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a…
Read More
Maryland life science & digital health companies drive record VC investment. | Maryland Business News
In 2021, venture capitalists invested $2.27 billion in Maryland companies, according to the initial figures from the PitchBook-NVCA Venture Monitor Report. VC investment in…
Read More
CoapTech Awarded Seed Fund Grant from Pennsylvania Pediatric Device Consortium
BALTIMORE, Jan. 27, 2022 /PRNewswire/ -- CoapTech, Inc, a medical device company focused on delivering transformative solutions for minimally-invasive surgery, announced today it has been awarded a $50,000 grant by the…
Read More
Immunocore announces FDA approval of KIMMTRAK® (tebentafusp-tebn) for the treatment of unresectable or metastatic uveal melanoma :: Immunocore PLC
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, Wednesday, January 26, 2022) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage…
Read More
QIAGEN Completes U.S. Federal Contract to Equip Local Public Health Authorities with QIAcuity Digital PCR System for COVID-19 Surveillance | BioSpace
HILDEN, Germany, & GERMANTOWN, Md.--(BUSINESS WIRE)-- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has completed a U.S. government contract to…
Read More
Trends in Talent Acquisition, COVID Edition · BioBuzz
The pandemic, now approaching year three in full force, has impacted nearly every facet of the life sciences’ job market. A talent shortage existed…
Read More
Looking Back with Pride—and Forward with Purpose
At the University System of Maryland, January brings with it the chance to reflect on a year of accomplishment and anticipate a year of…
Read More
Entrepreneurial Development | Seed
The SEED Innovator Support Team helps NIH awardees build a business and explore their life science innovation's potential. Learn about the aspects of product development…
Read More
Cartesian Therapeutics Doses Patient with First Allogeneic RNA Cell Therapy for Multiple Myeloma – Cartesian
Gaithersburg, Md., January 25, 2022 – Cartesian Therapeutics, a fully integrated clinical-stage biotechnology company pioneering RNA cell therapy in and beyond oncology, today announced…
Read More
Vaccitech CEO Bill Enright Joins Rich Bendis on First BioTalk of 2022
Bill visits BioTalk to talk about being a serial entrepreneur, biotech executive, and their recent acquisition of Avidea Technologies. Listen now via Apple https://apple.co/3fTySQM, Google https://bit.ly/3KDPMkh,…
Read More